Skip to main content

Table 2 Laboratory and radiology findings at admission

From: Risk factors for mortality in hospitalized patients with COVID-19 at the start of the pandemic in Belgium: a retrospective cohort study

 

All patients

(n = 319)

Discharged

(n = 238)

Deceased

(n = 81)

p-value

Laboratory findings

 White blood cell count (×10*9/L)

6.33 (4.89–8.50)

6.27 (4.80–8.41)

6.63 (5.16–8.97)

0.2258

   - > 10

45/315 (14.29)

31/236 (13.14)

14/79 (17.72)

0.3505

   - < 4

37/315 (11.75)

25/236 (10.59)

12/79 (15.19)

0.1795

   - Not measured

4

2

2

 

 Lymphocyte count (×10*9/L)

0.75 (0.49–1.12)

0.81 (0.53–1.21)

0.63 (0.32–0.92)

0.0720

   - < 1

211/314 (67.20)

150/236 (63.56)

61/78 (78.21)

0.0097

   - Not measured

5

2

3

 

 Platelet count (×10*9/L)

191 (157–254)

196 (162–255)

171 (126–243)

0.0089

   - < 150

71/316 (22.47)

42/237 (17.72)

29/79 (36.71)

0.0003

   - Not measured

3

1

2

 

 C-reactive protein (mg/L)

76 (31–130)

68 (28–110)

96 (46–160)

0.0120

   - Not measured

7

4

3

 

 Lactate dehydrogenase (U/L)

320 (250–420)

300 (230–400)

390 (280–475)

< 0.0001

   - Not measured

42

33

9

 

 Ferritin (ug/L)

840 (390–1600)

735 (370–1500)

1200 (490–2100)

0.0073

   - Not measured

90

62

28

 

 D-dimer (mg/L)

0.83 (0.53–1.41)

0.78 (0.51–1.28)

1.06 (0.62–1.67)

0.3039

   - > 0.5 mg/L

185/237 (78.06)

133/177 (75.14)

52/60 (86.67)

0.1878

   - Not measured

82

61

21

 

 Aspartate aminotransferase (U/L)

39 (28–56)

39 (26–54)

41 (31–60)

0.4091

   - Not measured

12

7

5

 

 Alanine aminotransferase (U/L)

28 (20–43)

28 (20–43)

28 (20–43)

0.4939

   - Not measured

13

8

5

 

 Gamma-glutamyl transferase (U/L)

45 (26–87)

46 (25–86)

42 (27–87)

0.5703

   - Not measured

22

14

8

 

 Alkaline phosphatase (U/L)

68 (57–93)

67 (57–93)

70 (58–90)

0.4856

   - Not measured

28

19

9

 

 Total bilirubin (mg/dl)

0.49 (0.38–0.68)

0.49 (0.38–0.67)

0.56 (0.38–0.72)

0.9666

   - Not measured

24

15

9

 

 Creatinine (mg/dl)

0.99 (0.79–1.31)

0.94 (0.76–1.17)

1.24 (0.92–2.21)

< 0.0001

   - Not measured

9

7

2

 

 eGFR (mL/min/1.73 m*2)b

70 (48–87)

74 (58–91)

48 (25–71)

< 0.0001

   - Not measured

10

8

2

 

 Sodium (mmol/L)

137 (135–140)

137 (134–139)

138 (135–141)

0.7515

   - Not measured

7

5

2

 

 Potassium (mmol/L)

3.94 (3.60–4.26)

3.91 (3.60–4.26)

3.97 (3.58–4.26)

0.4519

   - Not measured

7

5

2

 

Arterial blood gas

 pH

7.48 (7.45–7.51)

7.48 (7.45–7.52)

7.47 (7.43–7.48)

0.0091

  - Not measured

69

50

19

 

 pO2 without suppl oxygen (mmHg)

63 (55–71)

64 (56–73)

58 (50–67)

0.0190

   - Hypoxemiaa — no. (%)

212/241 (87.97)

158/183 (86.34)

54/58 (93.10)

0.1105

   - Not measured

78

55

23

 

 pCO2 (mmHg)

31 (28–34)

31 (28–35)

31 (28–34)

0.8152

   - Not measured

78

55

23

 

 Lactate

1.50 (1.10–1.90)

1.40 (1.10–1.80)

1.60 (1.30–2.30)

0.0020

   - Not measured

119

95

24

 

Radiology findings

 Infiltrates on chest X-ray

205/292 (70.21)

154/220 (70.00)

51/72 (70.83)

0.8931

   - Unilateral

64/292 (21.92)

49/220 (22.27)

15/72 (20.83)

0.7165

   - Bilateral

140/292 (47.95)

104/220 (47.27)

36/72 (50.0)

0.6846

  1. aHypoxemia was defined as a PaO2 < 80 mmHg
  2. bestimated glomerular filtration rate (eGFR) estimated using the CKD-EPI (Chronic Kidney Disease
  3. Epidemiology Collaboration) equation